Global Diabetic Peripheral Neuropathy Treatment Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Diabetic Peripheral Neuropathy Treatment

• 1.1 Definition of Diabetic Peripheral Neuropathy Treatment
• 1.2 Diabetic Peripheral Neuropathy Treatment Segment by Type
  • 1.2.1 Global Diabetic Peripheral Neuropathy Treatment Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Antimunocel
  • 1.2.3 ASP-8477
  • 1.2.4 BNV-222
  • 1.2.5 Capsaicin
  • 1.2.6 CBX-129801
  • 1.2.7 Others
• 1.3 Diabetic Peripheral Neuropathy Treatment Segment by Applications
  • 1.3.1 Global Diabetic Peripheral Neuropathy Treatment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Diabetic Peripheral Neuropathy Treatment Overall Market
  • 1.4.1 Global Diabetic Peripheral Neuropathy Treatment Revenue (2014-2025)
  • 1.4.2 Global Diabetic Peripheral Neuropathy Treatment Production (2014-2025)
  • 1.4.3 North America Diabetic Peripheral Neuropathy Treatment Status and Prospect (2014-2025)
  • 1.4.4 Europe Diabetic Peripheral Neuropathy Treatment Status and Prospect (2014-2025)
  • 1.4.5 China Diabetic Peripheral Neuropathy Treatment Status and Prospect (2014-2025)
  • 1.4.6 Japan Diabetic Peripheral Neuropathy Treatment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Diabetic Peripheral Neuropathy Treatment Status and Prospect (2014-2025)
  • 1.4.8 India Diabetic Peripheral Neuropathy Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Diabetic Peripheral Neuropathy Treatment
• 2.3 Manufacturing Process Analysis of Diabetic Peripheral Neuropathy Treatment
• 2.4 Industry Chain Structure of Diabetic Peripheral Neuropathy Treatment

3 Development and Manufacturing Plants Analysis of Diabetic Peripheral Neuropathy Treatment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Diabetic Peripheral Neuropathy Treatment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Diabetic Peripheral Neuropathy Treatment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Diabetic Peripheral Neuropathy Treatment Production and Capacity Analysis
• 4.2 Diabetic Peripheral Neuropathy Treatment Revenue Analysis
• 4.3 Diabetic Peripheral Neuropathy Treatment Price Analysis
• 4.4 Market Concentration Degree

5 Diabetic Peripheral Neuropathy Treatment Regional Market Analysis

• 5.1 Diabetic Peripheral Neuropathy Treatment Production by Regions
  • 5.1.1 Global Diabetic Peripheral Neuropathy Treatment Production by Regions
  • 5.1.2 Global Diabetic Peripheral Neuropathy Treatment Revenue by Regions
• 5.2 Diabetic Peripheral Neuropathy Treatment Consumption by Regions
• 5.3 North America Diabetic Peripheral Neuropathy Treatment Market Analysis
  • 5.3.1 North America Diabetic Peripheral Neuropathy Treatment Production
  • 5.3.2 North America Diabetic Peripheral Neuropathy Treatment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Diabetic Peripheral Neuropathy Treatment Import and Export
• 5.4 Europe Diabetic Peripheral Neuropathy Treatment Market Analysis
  • 5.4.1 Europe Diabetic Peripheral Neuropathy Treatment Production
  • 5.4.2 Europe Diabetic Peripheral Neuropathy Treatment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Diabetic Peripheral Neuropathy Treatment Import and Export
• 5.5 China Diabetic Peripheral Neuropathy Treatment Market Analysis
  • 5.5.1 China Diabetic Peripheral Neuropathy Treatment Production
  • 5.5.2 China Diabetic Peripheral Neuropathy Treatment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Diabetic Peripheral Neuropathy Treatment Import and Export
• 5.6 Japan Diabetic Peripheral Neuropathy Treatment Market Analysis
  • 5.6.1 Japan Diabetic Peripheral Neuropathy Treatment Production
  • 5.6.2 Japan Diabetic Peripheral Neuropathy Treatment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Diabetic Peripheral Neuropathy Treatment Import and Export
• 5.7 Southeast Asia Diabetic Peripheral Neuropathy Treatment Market Analysis
  • 5.7.1 Southeast Asia Diabetic Peripheral Neuropathy Treatment Production
  • 5.7.2 Southeast Asia Diabetic Peripheral Neuropathy Treatment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Diabetic Peripheral Neuropathy Treatment Import and Export
• 5.8 India Diabetic Peripheral Neuropathy Treatment Market Analysis
  • 5.8.1 India Diabetic Peripheral Neuropathy Treatment Production
  • 5.8.2 India Diabetic Peripheral Neuropathy Treatment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Diabetic Peripheral Neuropathy Treatment Import and Export

6 Diabetic Peripheral Neuropathy Treatment Segment Market Analysis (by Type)

• 6.1 Global Diabetic Peripheral Neuropathy Treatment Production by Type
• 6.2 Global Diabetic Peripheral Neuropathy Treatment Revenue by Type
• 6.3 Diabetic Peripheral Neuropathy Treatment Price by Type

7 Diabetic Peripheral Neuropathy Treatment Segment Market Analysis (by Application)

• 7.1 Global Diabetic Peripheral Neuropathy Treatment Consumption by Application
• 7.2 Global Diabetic Peripheral Neuropathy Treatment Consumption Market Share by Application (2014-2019)

8 Diabetic Peripheral Neuropathy Treatment Major Manufacturers Analysis

• 8.1 Achelios Therapeutics Inc
  • 8.1.1 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.1.2 Achelios Therapeutics Inc Product Introduction, Application and Specification
  • 8.1.3 Achelios Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Celgene Corp
  • 8.2.1 Celgene Corp Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.2.2 Celgene Corp Product Introduction, Application and Specification
  • 8.2.3 Celgene Corp Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Commence Bio Inc
  • 8.3.1 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.3.2 Commence Bio Inc Product Introduction, Application and Specification
  • 8.3.3 Commence Bio Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Grunenthal GmbH
  • 8.4.1 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.4.2 Grunenthal GmbH Product Introduction, Application and Specification
  • 8.4.3 Grunenthal GmbH Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Immune Pharmaceuticals Inc
  • 8.5.1 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.5.2 Immune Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.5.3 Immune Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 KPI Therapeutics Inc
  • 8.6.1 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.6.2 KPI Therapeutics Inc Product Introduction, Application and Specification
  • 8.6.3 KPI Therapeutics Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Medifron DBT Co Ltd
  • 8.7.1 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.7.2 Medifron DBT Co Ltd Product Introduction, Application and Specification
  • 8.7.3 Medifron DBT Co Ltd Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Mitsubishi Tanabe Pharma Corp
  • 8.8.1 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.8.2 Mitsubishi Tanabe Pharma Corp Product Introduction, Application and Specification
  • 8.8.3 Mitsubishi Tanabe Pharma Corp Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Novaremed Ltd
  • 8.9.1 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.9.2 Novaremed Ltd Product Introduction, Application and Specification
  • 8.9.3 Novaremed Ltd Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Reata Pharmaceuticals Inc
  • 8.10.1 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Production Sites and Area Served
  • 8.10.2 Reata Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.10.3 Reata Pharmaceuticals Inc Diabetic Peripheral Neuropathy Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Relief Therapeutics Holding AG
• 8.12 ViroMed Co Ltd

9 Development Trend of Analysis of Diabetic Peripheral Neuropathy Treatment Market

• 9.1 Global Diabetic Peripheral Neuropathy Treatment Market Trend Analysis
  • 9.1.1 Global Diabetic Peripheral Neuropathy Treatment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Diabetic Peripheral Neuropathy Treatment Regional Market Trend
  • 9.2.1 North America Diabetic Peripheral Neuropathy Treatment Forecast 2019-2025
  • 9.2.2 Europe Diabetic Peripheral Neuropathy Treatment Forecast 2019-2025
  • 9.2.3 China Diabetic Peripheral Neuropathy Treatment Forecast 2019-2025
  • 9.2.4 Japan Diabetic Peripheral Neuropathy Treatment Forecast 2019-2025
  • 9.2.5 Southeast Asia Diabetic Peripheral Neuropathy Treatment Forecast 2019-2025
  • 9.2.6 India Diabetic Peripheral Neuropathy Treatment Forecast 2019-2025
• 9.3 Diabetic Peripheral Neuropathy Treatment Market Trend (Product Type)
• 9.4 Diabetic Peripheral Neuropathy Treatment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Diabetic Peripheral Neuropathy Treatment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List